These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32541670)

  • 1. Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia.
    Vu T; Straube J; Porter AH; Bywater M; Song A; Ling V; Cooper L; Pali G; Bruedigam C; Jacquelin S; Green J; Magor G; Perkins A; Chalk AM; Walkley CR; Heidel FH; Mukhopadhyay P; Cloonan N; Gröschel S; Mallm JP; Fröhling S; Scholl C; Lane SW
    Nat Commun; 2020 Jun; 11(1):3021. PubMed ID: 32541670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
    Jafek JL; Shakya A; Tai PY; Ibarra A; Kim H; Maddox J; Chumley J; Spangrude GJ; Miles RR; Kelley TW; Tantin D
    Exp Hematol; 2019 Aug; 76():38-48.e2. PubMed ID: 31295506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia.
    Rawat VP; Cusan M; Deshpande A; Hiddemann W; Quintanilla-Martinez L; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):817-22. PubMed ID: 14718672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis.
    Scholl C; Bansal D; Döhner K; Eiwen K; Huntly BJ; Lee BH; Rücker FG; Schlenk RF; Bullinger L; Döhner H; Gilliland DG; Fröhling S
    J Clin Invest; 2007 Apr; 117(4):1037-48. PubMed ID: 17347684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of CDX2 in leukemia: A new perspective for leukemia research.
    Darvishi M; Mashati P; Khosravi A
    Leuk Res; 2018 Sep; 72():45-51. PubMed ID: 30096576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOX gene regulation in acute myeloid leukemia: CDX marks the spot?
    Fröhling S; Scholl C; Bansal D; Huntly BJ
    Cell Cycle; 2007 Sep; 6(18):2241-5. PubMed ID: 17881901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
    Faber K; Bullinger L; Ragu C; Garding A; Mertens D; Miller C; Martin D; Walcher D; Döhner K; Döhner H; Claus R; Plass C; Sykes SM; Lane SW; Scholl C; Fröhling S
    J Clin Invest; 2013 Jan; 123(1):299-314. PubMed ID: 23202735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MSI2 is required for maintaining activated myelodysplastic syndrome stem cells.
    Taggart J; Ho TC; Amin E; Xu H; Barlowe TS; Perez AR; Durham BH; Tivnan P; Okabe R; Chow A; Vu L; Park SM; Prieto C; Famulare C; Patel M; Lengner CJ; Verma A; Roboz G; Guzman M; Klimek VM; Abdel-Wahab O; Leslie C; Nimer SD; Kharas MG
    Nat Commun; 2016 Feb; 7():10739. PubMed ID: 26898884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
    Schinke C; Giricz O; Li W; Shastri A; Gordon S; Barreyro L; Bhagat T; Bhattacharyya S; Ramachandra N; Bartenstein M; Pellagatti A; Boultwood J; Wickrema A; Yu Y; Will B; Wei S; Steidl U; Verma A
    Blood; 2015 May; 125(20):3144-52. PubMed ID: 25810490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia.
    Rawat VP; Thoene S; Naidu VM; Arseni N; Heilmeier B; Metzeler K; Petropoulos K; Deshpande A; Quintanilla-Martinez L; Bohlander SK; Spiekermann K; Hiddemann W; Feuring-Buske M; Buske C
    Blood; 2008 Jan; 111(1):309-19. PubMed ID: 17855634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine.
    Miltiades P; Lamprianidou E; Vassilakopoulos TP; Papageorgiou SG; Galanopoulos AG; Kontos CK; Adamopoulos PG; Nakou E; Vakalopoulou S; Garypidou V; Papaioannou M; Hatjiharissi E; Papadaki HA; Spanoudakis E; Pappa V; Scorilas A; Tsatalas C; Kotsianidis I;
    Clin Cancer Res; 2016 Apr; 22(8):1958-68. PubMed ID: 26700206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to
    Porter SN; Cluster AS; Yang W; Busken KA; Patel RM; Ryoo J; Magee JA
    Elife; 2016 Nov; 5():. PubMed ID: 27879203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor of activated T-cells, NFATC1, governs FLT3
    Solovey M; Wang Y; Michel C; Metzeler KH; Herold T; Göthert JR; Ellenrieder V; Hessmann E; Gattenlöhner S; Neubauer A; Pavlinic D; Benes V; Rupp O; Burchert A
    J Hematol Oncol; 2019 Jul; 12(1):72. PubMed ID: 31286998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
    Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
    Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
    Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
    Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
    Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
    Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia.
    Riedt T; Ebinger M; Salih HR; Tomiuk J; Handgretinger R; Kanz L; Grünebach F; Lengerke C
    Blood; 2009 Apr; 113(17):4049-51. PubMed ID: 19218548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
    Bernasconi P
    Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells.
    Ingenhag D; Reister S; Auer F; Bhatia S; Wildenhain S; Picard D; Remke M; Hoell JI; Kloetgen A; Sohn D; Jänicke RU; Koegler G; Borkhardt A; Hauer J
    Haematologica; 2019 Jan; 104(1):35-46. PubMed ID: 30093397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.